Christopher Scrase

Betsi Cadwaladr University Health Board — United Kingdom

Medicine · Health Sciences

29h-index7.3kcitations68works9.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(32), Prostate Cancer Diagnosis and Treatment(30), Advanced Radiotherapy Techniques(29), Head and Neck Cancer Studies(12), Lung Cancer Diagnosis and Treatment(6)

Publications66 total

POPS: a randomised trial of image-guided prostate bed radiotherapy using the rectal obturator ProSpare® (NCT02978014): Acute toxicity and dosimetry
European Urology Open Science·2025Open Access
Radiotherapy quality assurance for the PEACE 1 trial: An individual case review analysis
Radiotherapy and Oncology·2025Open Access
Radiotherapy Quality Assurance for the Peace 1 Trial: An Individual Case Review Analysis
SSRN Electronic Journal·2024Open Access
Acceptability and effectiveness of digital prehabilitation and personalised support for patients with cancer in the UK National Health Service.
Journal of Clinical Oncology·2023
10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016).
Journal of Clinical Oncology·2023· 24 cited
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19
JAMA Network Open·2022· 58 citedOpen Access
Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP Trial
International Journal of Radiation Oncology*Biology*Physics·2022· 7 citedOpen Access
Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016)
European Urology Oncology·2021· 38 citedOpen Access
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease
Journal of Clinical Oncology·2021· 46 citedOpen Access
Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trial
European Journal of Cancer·2021· 16 cited
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme
The Lancet·2021· 40 citedOpen Access
Radiotherapy Training Programs in Lower- and Middle-Income Countries (LMIC) of Africa: Experience of the International Atomic Energy Agency (IAEA) in Upskilling Contouring Competencies in Disease Specific Sites - Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics·2020· 1 cited
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
The Lancet Oncology·2020· 599 citedOpen Access
Sequential or concomitant radiotherapy treatment for patients with localized prostate cancer.
Journal of Clinical Oncology·2020
Eight-year outcomes of a phase III randomized trial of conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): Update from the CHHiP Trial.
Journal of Clinical Oncology·2020· 8 cited
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial
Clinical and Translational Radiation Oncology·2019· 32 citedOpen Access
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer
Radiotherapy and Oncology·2019· 48 citedOpen Access
Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity
Clinical Oncology·2019· 4 citedOpen Access
Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)
International Journal of Radiation Oncology*Biology*Physics·2018· 66 citedOpen Access
Impact of Prostate Cancer Hypofractionation on Patient Reported Outcomes: Baseline to 5 Years Change in the CHHIP Trial
International Journal of Radiation Oncology*Biology*Physics·2018· 8 cited
page 1 of 4Next →

Frequent Co-authors

Emma Hall(24), David P. Dearnaley(21), Isabel Syndikus(21), Vincent Khoo(16), Clare Griffin(15), John D. Graham(13), John Staffurth(13), Alison Birtle(10), Miguel Panades(10), Joe M. O’Sullivan(9), Chris Parker(9), Olivia Naismith(9), Clare Cruickshank(9), Helen Mayles(8), John Logue(7), Shama Hassan(7), Kevin J. Harrington(6), Helen Mossop(6), David Bloomfield(6), Zafar Malik(6)